"10.1371_journal.pone.0067330","plos one","2013-06-28T00:00:00Z","Aur√©lie Courtin; Frances M Richards; Tashinga E Bapiro; Jo L Bramhall; Albrecht Neesse; Natalie Cook; Ben-Fillippo Krippendorff; David A Tuveson; Duncan I Jodrell","Pharmacology and Drug Development Group, Cancer Research UK Cambridge Research Institute, Cambridge, United Kingdom; Tumour Modelling and Experimental Medicine Group, Cancer Research UK Cambridge Research Institute, Cambridge, United Kingdom; University of Cambridge Department of Oncology, Cambridge, United Kingdom, Cambridge, United Kingdom","Conceived and designed the experiments: AC FR DJ. Performed the experiments: AC FR TB JB NC. Analyzed the data: AC FR BFK AN. Contributed reagents/materials/analysis tools: DT BFK. Wrote the paper: AC FR DJ.","DJ has received support for Clinical Trials from Roche and has also served on an editorial board for the Xeloda (Capecitabine) web site. This study was funded in part by Hutchison-Whampoa Ltd in the form of a charitable donation to the CRUK Cambridge Institute which contributed to the salary of DT. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. All other authors declare that no competing interests exist.","2013","06","Aur√©lie Courtin","A√C",9,FALSE,3,5,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
